Skip to main content

Daphne Ruth Friedman

Professor of Medicine
Medicine, Medical Oncology
508 Fulton Street (111G), Durham, NC 27705
508 Fulton Street (111G), Durham VA Medical Center, Durham, NC 27705

Overview


My area of expertise is in leukemias and lymphomas, including Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. My research interests are focused on improving treatment options for patients with hematologic malignancies, through laboratory and clinical research.  I am also a staff physician at the Durham VA Medical Center, and am deeply committed to expanding treatment options for veterans, including working on clinical trials for multiple myeloma, prostate cancer, and lung cancer at the Durham VA.

Current Appointments & Affiliations


Professor of Medicine · 2024 - Present Medicine, Medical Oncology, Medicine
Member of the Duke Cancer Institute · 2013 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Association Between Monoclonal Gammopathy of Undetermined Significance and Cardiovascular Disease Risk: A Veterans Health Administration Study.

Journal Article J Am Heart Assoc · January 6, 2026 BACKGROUND: Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased risk of cardiovascular disease (CVD). However, its potential to provide additional prognostic information beyond traditional CVD risk assessments remains ... Full text Link to item Cite

Quality of Care in Veterans Affairs Health Care System In-Person and National TeleOncology Service-Delivered Care.

Journal Article JCO Oncol Pract · December 2025 PURPOSE: The Veterans Affairs Health Administration (VA) has experience using telehealth (TH) to deliver care to 10 million enrolled Veterans for many clinical care needs. The VA National TeleOncology Service (NTO) was established in 2020 to provide specia ... Full text Link to item Cite

Cancer decentralized clinical trials in the veterans health administration.

Journal Article J Natl Cancer Inst · September 24, 2025 BACKGROUND: Despite the importance of clinical trials (CTs) in the advancement of cancer treatments, there are barriers to subject enrollment. Decentralized clinical trials (DCTs) are conducted at a different physical location than where patients receive m ... Full text Link to item Cite
View All Publications

Recent Grants


Experience of Veterans with Myeloproliferative Neoplasms

ResearchCo-Mentor · Awarded by American Society of Clinical Oncology · 2025 - 2026

View All Grants

Education, Training & Certifications


University of Maryland, College Park · 2002 M.D.